⌘K

Login Start Free

Home/Filings/4/0001209191-23-016340

4//SEC Filing

DesJardin Michael A. 4

Accession 0001209191-23-016340

CIK 0001492426other

View on SEC.gov Company Profile

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 4:48 PM ET

Size

10.8 KB

Accession

0001209191-23-016340

Insider Transaction Report

Form 4

Period: 2023-03-02

Horizon Therapeutics Public Ltd CoHZNP

DesJardin Michael A.

EVP, Technical Operations

Transactions

Exercise/Conversion
Ordinary Shares
2023-03-02$14.93/sh+3,629$54,181→ 125,815 total
Exercise/Conversion
Ordinary Shares
2023-03-02$17.19/sh+743$12,772→ 126,558 total
Exercise/Conversion
Stock Option (Right to Buy)
2023-03-02−3,629→ 0 total
Exercise: $14.93Exp: 2026-12-14→ Ordinary Shares (3,629 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2023-03-02−743→ 0 total
Exercise: $17.19Exp: 2027-02-20→ Ordinary Shares (743 underlying)

Footnotes (1)

[F1]The stock option is fully vested.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Horizon Therapeutics Public Ltd Co

CIK 0001492426

Entity typeother

Related Parties

1

filerCIK 0001512985

Filing Metadata

Form type: 4
Filed: Mar 5, 7:00 PM ET
Accepted: Mar 6, 4:48 PM ET
Size: 10.8 KB

View on SEC.gov